- $8.08bn
- $7.20bn
- $937.46m
- 84
- 13
- 67
- 54
Annual balance sheet for Klaviyo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 328 | 386 | 739 | 881 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 6.29 | 10.7 | 23.1 | 43.1 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 356 | 428 | 803 | 980 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 89.7 | 91.5 | 80.4 | 91.1 |
Other Long Term Assets | ||||
Total Assets | 464 | 629 | 1,089 | 1,273 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 77 | 85 | 131 | 200 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 134 | 133 | 174 | 239 |
Redeemable Preferred Stock | ||||
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 330 | 496 | 915 | 1,034 |
Total Liabilities & Shareholders' Equity | 464 | 629 | 1,089 | 1,273 |
Total Common Shares Outstanding |